Use Of Carbamate Compound For Prevention, Alleviation, Or Treatment Of Demyelinating Disease

A method for preventing, alleviating or treating demyelinating diseases in a subject, comprising administering to the subject a therapeutically effective amount of a carbamate compound of the following Formula 1, or a pharmaceutically acceptable salt, solvate or hydrate thereof:

• wherein,
• R1 and R2 are each independently selected from the group consisting of hydrogen, halogen, C1-C8 alkyl, halo-C1-C8 alkyl, C1-C8 thioalkoxy and C1-C8 alkoxy;
• and
• one of A1 and A2 is CH, and the other is N.